Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Braven Partners is a venture capital firm founded to support founders in developing system innovations within regulated industries. Established by former leaders from BlackRock and Apollo Global Management, the firm is headquartered in New York City at 430 Park Avenue. Braven focuses on co-building companies that address significant opportunities in sectors such as financial services, insurance, and healthcare.
The firm has invested over $1 billion in early-stage companies and has achieved more than eight successful exits across various sectors, including technology, healthcare, finance, and insurance. Braven's approach emphasizes operational involvement, leveraging deep industry expertise and networks to help portfolio companies navigate regulatory complexities. This hands-on model distinguishes Braven from traditional venture capital firms.
Braven Partners invests primarily in early-stage companies within the fintech, healthcare, and biotech sectors. The firm provides capital from seed through Series B rounds, with check sizes ranging from $1 million to $15 million. Braven emphasizes co-building initiatives that enhance growth potential through specialized support in team formation, sales development, and capital formation.
The firm's investment strategy targets breakthrough innovations within regulated ecosystems, particularly in financial services and healthcare. Braven seeks to develop next-generation insurance and financial infrastructure, as well as platforms for proactive and personalized patient care. This focus on regulated industries allows Braven to leverage its team's extensive experience and connections, providing portfolio companies with the necessary resources to thrive in complex environments.
Braven Partners has invested over $1 billion in early-stage companies, achieving more than eight exits across various sectors. While specific portfolio companies were not detailed, the firm is recognized for its active co-building model in regulated sectors. The focus on fintech, healthcare, and biotech aligns with Braven's commitment to supporting innovations that address significant market needs.
Notable sectors of investment include:
William Abecassis - Managing Partner and Chief Investment Officer. He has a background in leading investment strategies at BlackRock.
LizAnn Eisen - Senior Partner, Regulatory & Strategy. She brings expertise in navigating regulatory frameworks within financial services.
Bradford Wilkins - Senior Partner, Talent & Performance. He focuses on building high-performing teams within portfolio companies.
Joel Herold - Co-Build Partner, Financial Services & Insurance. He leads initiatives in developing innovative solutions in these sectors.
Additional team members include Margaret Berno, Prithvi Addepalli, Kiran Yemul, Eddie Lei, Jon Terenzetti, Jeremy Chizewer, Jay Krzyston, PhD, Adam King, Deborah Chase Hopkins, Irving Wladawsky-Berger, PhD, Philip Gelston, Bill Priestap, and Ross Levinsky, PhD. Their roles were not specified, but they contribute to the firm's diverse expertise.
To pitch Braven Partners, founders should visit their website at Braven Partners for guidance on the preferred application process. It is advisable to include a comprehensive deck that outlines the business model, market opportunity, and team qualifications. While specific response time expectations were not provided, founders should anticipate a thorough review process given the firm's hands-on approach.
Braven Partners has recently launched a Financial Services & Insurance Innovation Unit, appointing Joel Herold as Co-Build Partner. This initiative reflects the firm's commitment to actively co-building companies within regulated sectors.
As of now, Braven has invested over $1 billion in early-stage companies and achieved more than eight successful exits. The firm continues to focus on breakthrough innovations in financial services, insurance, and healthcare.
What are Braven Partners' investment criteria?
Braven Partners primarily invests in early-stage companies within regulated industries, focusing on fintech, healthcare, and biotech. The firm provides capital from seed through Series B rounds, with check sizes ranging from $1 million to $15 million.
How can I apply or pitch to Braven Partners?
Founders interested in pitching to Braven Partners can visit their website at Braven Partners for more information on the application process. Specific email addresses for pitches were not provided.
What makes Braven Partners different from other venture capital firms?
Braven Partners distinguishes itself through its co-building approach, providing operational support and strategic guidance to portfolio companies. The firm's team has extensive backgrounds in leading financial institutions, which enhances their ability to navigate regulatory complexities.
What is Braven Partners' geographic focus?
The firm primarily operates within the United States, targeting early-stage companies that are addressing significant opportunities in regulated sectors.
What kind of post-investment involvement does Braven Partners have?
Braven Partners takes an active role in supporting its portfolio companies, offering specialized assistance in areas such as team formation, sales development, and capital formation. This hands-on involvement helps enhance the growth potential of their investments.
What is the typical check size for investments made by Braven Partners?
Braven Partners typically invests between $1 million and $15 million in early-stage companies, allowing for flexibility in funding across different stages of growth.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.